Summary
Optimal antiplatelet therapy has been a source of contention, primarily due to conflicting trial data. There remain many unanswered questions regarding the role of platelet response testing, drug interactions, and bleeding risk in the clinical setting.
- Thrombotic Disorders
- Myocardial Infarction
- © 2010 MD Conference Express